AbbVie announces €40 million investment in Sligo

AbbVie is to expand its medical device manufacturing facility in Sligo, creating 50 highly-skilled jobs over the next four years.

The biopharmaceutical company, which was formed in 2013 following separation from Abbott Laboratories, is investing €40 million in its manufacturing facility at Ballytivnan in Sligo.

The company’s manufacturing site in Ballytivnan currently produces drug delivery devices, including a pen-style injector that is used by patients around the world who use AbbVie’s treatment indicated for a range of auto-immune conditions.

Including today’s announcement, AbbVie’s investment in Ballytivnan and broader manufacturing operations in the country has reached more than €134 million since 2013.

AbbVie employs more than 500 people at five different sites around the country, including three manufacturing plants – two in Sligo and one in Cork. The research-based biopharmaceutical company was formed in 2013 following separation from Abbott Laboratories.